Diagnosis: Herpes zoster (thoracic dermatome) in an immunocompetent young adult
Herpes zoster is increasingly recognized in immunocompetent young adults, often precipitated by psychosocial stress. This case highlights a 28-year-old woman who developed a painful unilateral vesicular rash following significant stress. Early initiation of oral antiviral therapy within 72 hours of rash onset is critical to reduce both acute pain and the risk of post-herpetic neuralgia.
A 28-year-old otherwise healthy woman presents with a 4-day history of a painful unilateral burning/tingling band on the left mid-trunk. On examination, there are strictly unilateral grouped vesicles on an erythematous base in a single thoracic dermatome, respecting the midline.Dermatomal distribution: Vesicles follow the left T6-T8 dermatomes.Lesions in different stages: Grouped vesicles and pustules noted.Prodromal neuropathic pain: Mild burning pain preceded the rash by 2-3 days.Midline respect: Lesions do not cross the midline.No motor or ocular involvement: Examination reveals no associated neurologic deficits.
The patient reports a prodrome of burning and tingling that began 2-3 days before the rash appeared. Over the past 4 days, an erythematous patch evolved into grouped vesicles and pustules, confined to the left mid-trunk. She has experienced significant psychosocial stress due to final exams and a major work project, along with poor sleep, which appears to be the most plausible precipitant. Notably, she is otherwise healthy with no history of immunosuppression.Prior varicella infection during childhood, establishing her as a candidate for zoster.No zoster vaccine received yet at her age.No known HIV risk factors, malignancy, or history of organ transplant.Not currently pregnant and no exposure to a non-immune contact.
Acute / First-Line ManagementInitiate oral antiviral therapy ideally within 72 hours of rash onset: valacyclovir 1 g PO TID for 7 days (preferred for convenience) or famciclovir 500 mg PO TID for 7 days, or acyclovir 800 mg PO five times daily for 7 days.Provide analgesia with acetaminophen/NSAIDs; consider gabapentin or a short course of low-dose tricyclic for moderate-to-severe neuropathic pain.Encourage the use of cool compresses and loose clothing for comfort.Educate the patient that vesicular fluid contains VZV, advising to cover lesions and avoid contact with pregnant non-immune women, infants, and immunocompromised individuals until lesions crust over.Workup and Diagnostic ConfirmationDiagnosis is typically clinical; however, PCR of vesicular fluid is the gold standard for confirmation (more sensitive than DFA and Tzanck smears).Routine HIV testing should be considered in young immunocompetent adults presenting with zoster, particularly if any risk factors or atypical/multidermatomal/recurrent disease is present.No need for routine malignancy workup if presentation is otherwise classic and the patient is well.Long-Term ManagementMonitor for post-herpetic neuralgia (PHN), characterized by pain persisting >90 days after rash onset; risk increases with age but can occur in young adults.First-line PHN therapy includes gabapentin/pregabalin, TCAs, topical 5% lidocaine, and capsaicin 8% patch.Discuss the recombinant zoster vaccine (Shingrix), which is not currently routinely indicated for those under age 50 in immunocompetent adults, but may be considered in immunocompromised patients aged ≥18.Provide lifestyle advice on stress reduction and sleep hygiene as plausible modifiable triggers for zoster.
Zosteriform herpes simplex: Typically recurrent, with smaller affected areas, often anogenital or orofacial; PCR testing distinguishes it from zoster.Bullous impetigo: Characterized by honey-crusted superficial bullae, lacks dermatomal pattern and prodromal pain.Allergic contact dermatitis: Presents as a linear/banded pattern, often itchy rather than painful, with geographic borders matching exposure; true vesicles in different stages are absent.Inframammary intertrigo or candidiasis: Symmetrical with satellite pustules, lacks neuropathic pain and dermatomal limits.Bullous arthropod assault: Typically presents as asymmetric clusters with central puncta; history of bites is common.Early bullous pemphigoid: More common in older patients, begins as urticarial plaques leading to widespread tense bullae; immunofluorescence is positive.Disseminated zoster: Involves >20 vesicles outside the primary dermatome, warrants evaluation for underlying immunosuppression.
High-Yield PearlsDermatomal distribution: Strictly respects the midline, serving as a cardinal clue for diagnosis.72-hour window: For initiating antiviral therapy to effectively reduce acute pain and the risk of post-herpetic neuralgia.Psychosocial stress: Recognized as a common trigger for herpes zoster in otherwise healthy young adults.HIV testing: Should be considered in young immunocompetent adults presenting with zoster, particularly if risk factors are present.PHN risk: Understand the risk and first-line treatments, including gabapentin/pregabalin and TCAs.Contagiousness: Vesicular fluid can cause varicella in non-immune contacts; advise covering lesions until crusted.Shingrix indications: Current recommendations do not routinely include immunocompetent individuals under 50 years; however, vaccination may be considered in immunocompromised patients.Remember to consider 'shingles even in the young' when faced with a painful unilateral dermatomal vesicular eruption.
Tags: herpes zoster, shingles, VZV, thoracic dermatome, stress